See all
 |
Articles: Drug/Product Alerts |
Par Pharmaceutical Receives Final Approval To Market Generic Starlix
Par Pharmaceutical, 09/11/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Free full text
Insecticide Movento granted regulatory approval in Australia
BayNews International, 09/01/09
Free full text
Panel Will Consider Clinical Data Supporting Approval and Labeling
Genzyme, 08/31/09
Free full text
Medtronic Board Approves Second Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 08/28/09
Free full text
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
American Pharmaceutical Partners, 08/26/09
Free full text
Health Canada Approves Abbott's XIENCE V Drug Eluting Stent
Abbott, 08/25/09 Novartis receives approval in EU for Xolair to treat children age 6 to 11 years suffering from severe persistent allergic asthma
Novartis, 08/25/09
Free full text
Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review Designation for Rifaximin NDA for the Maintenance of Remission of Hepatic Encephalopathy
Salix Pharmaceuticals, 08/25/09
Free full text
Warner Chilcott Completes Irish Redomestication
Warner Chilcott, 08/24/09 Merck is Pleased the FDA and CDC Re-affirm the Safety Profile of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]
Merck & Co., 08/21/09
Free full text
Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement
Bristol Myers-Squibb Company, 08/21/09
Free full text
Dey Issues Advisory
Mylan, 08/21/09 Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)
Neuropsychopharmacology, 08/20/09 Fda accepts drug application for miconazole lauriad to treat oropharyngeal candidiasis
Par Pharmaceutical, 08/20/09 CryoLife Announces Implants of First FDA-Cleared SynerGraft Processed Human Cardiac Patch Material
Cryolife, 08/19/09
Free full text
Par pharmaceutical and aveva drug delivery systems receive final approval to market generic catapres tts
Par Pharmaceutical, 08/19/09 Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla HIV Treatment
Mylan, 08/19/09 US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
Novartis, 08/18/09
Free full text
BTG Collaborator Onyx Gains Approval to Progress Oncology Compound into Clinical Development
BTG, 08/18/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
144 Available Pages
|
|